DoD Peer Reviewed, Idea Award | W81XWH 22 PRCRP IA

Opportunity Information: Apply for W81XWH 22 PRCRP IA

The FY22 DoD Peer Reviewed Cancer Research Program (PRCRP) Idea Award is a Department of Defense funding opportunity meant to spark genuinely novel cancer research that could matter to active-duty Service Members, Veterans, other military beneficiaries, and the broader public. It is built specifically for early-stage, untested ideas that are high-risk but could pay off in a big way if they work. A major emphasis is placed on relevance to military populations and needs, including cancers or cancer-risk circumstances that may affect the support system around Service Members, such as military families. The larger purpose behind the award is to push forward knowledge that could improve cancer research directions, patient care, and/or treatment options within the Military Health System (MHS), where better tools and understanding can translate into real-world impact for military communities.

At its core, this award is about creativity and paradigm-shifting potential rather than safe or predictable progress. The program is looking for projects that introduce a new concept, challenge existing thinking, reframe a long-standing problem, or apply an unconventional method that could open a new path in cancer research. In other words, the value proposition is the boldness and originality of the approach. The Idea Award is not designed to fund incremental work, routine extensions of an established line of research, or a straightforward next step that naturally follows from what a lab is already doing. It also makes clear that simply moving an existing model or approach from one cancer type to another generally does not meet the innovation bar. Reviewers are being asked to look for proposals that take a real intellectual leap, even if the outcome is uncertain.

Even though the emphasis is on untested ideas, the proposed project still needs to be rigorous. Applicants are expected to present a well-formulated and testable hypothesis, supported by a strong scientific rationale and a study design that can realistically evaluate the central idea. The award is essentially saying: take a chance on something new, but do it with discipline, clarity, and a plan that can generate interpretable results. The Principal Investigator is also expected to choose the most appropriate PRCRP mechanism, because the Idea Award is not intended for projects that already have extensive preliminary data and are ready for more advanced development. If a project is already mature and supported by robust preliminary evidence, the solicitation points applicants toward the FY22 PRCRP Impact Award instead, which is positioned for more established, later-stage efforts.

Administratively, this opportunity was issued by the Department of Defense, Department of the Army, through USAMRAA, and is listed under CFDA 12.420 for science and technology research and development. The funding instrument types include grants and cooperative agreements, and eligibility is described as unrestricted, meaning it is broadly open to many entity types unless additional eligibility text adds constraints. The opportunity (W81XWH-22-PRCRP-IA) was created March 31, 2022, with an original closing date of September 7, 2022. The posting anticipated making around 35 awards, while the award ceiling is listed as 0 in the source data, which typically signals that applicants need to rely on the full announcement for budget limits or that the ceiling was not specified in the summarized field. Overall, the solicitation reads as a targeted push for unconventional, potentially transformative cancer research ideas with clear military relevance and a strong, testable plan for generating meaningful findings.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Peer Reviewed, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 31, 2022.
• Applicants must submit their applications by Sep 07, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 35 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 PRCRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: